Charles River and Toxys have entered into an agreement to offer access to ToxTracker® in North America.
Source: www.businesswire.com
Charles River Laboratories International (NYSE: CRL) and Toxys have inked an agreement to offer access to ToxTracker in North America. ToxTracker is a suite of assays that allow rapid carcinogenicity toxicity hazard identification in drugs, chemicals, and other substances. Toxys is a Dutch biotech company that offers a broad spectrum of in vitro toxicology solutions. Meanwhile, Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts.
